98%
921
2 minutes
20
The female reproductive system is highly complex, making it essential for applied research and translational medicine to accurately model its intricate physiological functions or develop strategies for restoring them. However, significant structural and functional differences between human and animal models, along with the limitations of static 2D cell culture technologies, underscore the need for more dynamic and sophisticated platforms, as well as therapies. These advancements are critical for deepening our understanding of reproductive biology and supporting clinical applications. Recent advancements in additive manufacturing technology have opened new frontiers in the study of the female reproductive system. By introducing diverse preclinical models and expanding the range of potential applications, this field has reached new heights, with the rapidly evolving research paradigm reshaping the scientific landscape. This review aims to summarize the growing body of evidence surrounding bioengineering strategies, platforms, and therapies in female reproductive medicine, with the goal of advancing our understanding of female reproductive biology and providing new avenues for fertility restoration. Specifically, we will examine the historical development, technological innovations, and scientific research related to the creation of 3D-engineered tissues for reconstructing the female reproductive system. Impact Statement This review aims to summarize the growing body of evidence surrounding bioengineering strategies, platforms, and therapies in female reproductive medicine, with the goal of advancing our understanding of female reproductive biology and providing new avenues for fertility restoration. Specifically, the historical development, technological innovations, and scientific research related to the 3D-engineered tissues for reconstructing the female reproductive system were summarized. This review would help the audience, especially bioengineers who study the female reproductive system disease, as well as obstetricians and gynecologists, understand the possible application of additive manufacturing and acquire the strategies to engineer the female reproductive system .
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/19373341251359111 | DOI Listing |
Am J Reprod Immunol
September 2025
Department of Obstetrics and Gynecology, Second XiangYa Hospital of Central South University, Changsha, Hunan, China.
Problem: Preeclampsia (PE) is a leading cause of perinatal maternal and fetal mortality. Clinical and pathological studies suggest that placental and decidual cell dysfunction may contribute to this condition. However, the pathogenesis of PE remains poorly understood.
View Article and Find Full Text PDFReproduction
October 2025
Maternal and Fetal Health Research Centre, University of Manchester, Manchester, United Kingdom.
In Brief: Advanced maternal age (AMA) is associated with adverse pregnancy outcomes, particularly those associated with placental dysfunction. This study showed that in a mouse model of AMA, male but not female fetuses had increased placental apoptosis and lipid peroxidation, as well as increased mitochondrial content, suggesting that the placentas of male fetuses in AMA mothers adapt to be able to deliver sufficient energy to the fetus.
Abstract: Although advanced maternal age (AMA) increases the risk of fetal growth restriction (FGR) and stillbirth, the mechanisms leading to the placental dysfunction observed in AMA are unknown.
Mol Hum Reprod
September 2025
Department of Obstetrics and Gynecology, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
Infertility impacts up to 17.5% of reproductive-aged couples worldwide. To aid in conception, many couples turn to assisted reproductive technology, such as IVF.
View Article and Find Full Text PDFOrv Hetil
September 2025
1 Szegedi Tudományegyetem, Szent-Györgyi Albert Orvostudományi Kar, Klinikai Központ, Fül-Orr-Gégészeti és Fej-Nyaksebészeti Klinika Szeged, Tisza Lajos körút 111., 6725 Magyarország.
JAMA Netw Open
September 2025
Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Importance: Exposure to inflammation from chorioamnionitis places the fetus at higher risk of premature birth and may increase the risk of neurodevelopmental impairments, though the evidence for the latter is mixed.
Objective: To evaluate whether moderate to severe histologic chorioamnionitis (HCA) is directly associated with adverse motor performance, independent of the indirect mediating effects of premature birth.
Design, Setting, And Participants: This prospective, population-based cohort study recruited participants between September 16, 2016, and November 19, 2019, from referral and nonreferral neonatal intensive care units of 5 southwestern Ohio hospitals.